SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Novo Nordisk CagriSema Shows 25.4% Mean Weight Loss in Early Responders

A post hoc analysis found 25.4% mean weight loss among early responders to Novo Nordisk's CagriSema.

Related stories